Q BioMed’s technology partner, Mannin Research, has entered a collaboration with McMaster University of Ontario focused on ophthalmic drug delivery and formulation for MAN-01, a first in class small molecule to treat Primary Open-Angle Glaucoma. Research will be conducted by Dr. Heather Sheardown, a leader in ophthalmic biomaterials and drug delivery. The collaboration will explore new and improved ways of delivering Mannin’s small molecules to the eye to treat glaucoma. Using the formulation...